Navigation Links
Masimo Initiates Full Market Release of First-Ever Noninvasive Continuous Hemoglobin Monitor
Date:3/24/2009

wnward hemoglobin trend on a second-by-second basis as it occurs has been of tremendous value."

Randy Marcel, MD, Medical Director and Chief of Anesthesiology at The Heart Hospital Baylor Plano in Plano, Texas, stated, "In the past, we've only received glimpses of our patients' hemoglobin levels from lab measurements, but now we have complete and real-time hemoglobin visibility. We initially purchased SpHb for use during cardiac surgeries in the OR, and brought in additional units for the ICU, where post-operative monitoring of internal bleeding is critical to patient recovery."

Javed Akhtar, MD, FAAP, Medical Director, Pediatric Intensive Care Unit at Creighton University Medical Center in Omaha, Nebraska, stated, "We purchased the SpHb monitor after seeing it in a hands-on demonstration, and I'm glad we did! SpHb has reduced the traumatic experience for pediatric patients, increased the satisfaction of parents, and reduced the workload on our nursing staff, phlebotomist and laboratory personnel."

Madhava Karunarathna, MD, OB/GYN at Balangoda Hospital in Sri Lanka, stated, "With SpHb, we now have accurate hemoglobin measurements available at our fingertips, around the clock. In cases of severe hemorrhaging during and after childbirth, SpHb has enabled us to immediately identify and continuously assess blood loss severity to better manage internal bleeding, prevent overloading of fluid, and decrease maternal death."

Adi Abdussalam Adham, MD, Chief Manager at Accidents Hospital Abu Saleem in Tripoli, Libya reinforced Dr. Karunarathna's comments, adding that: "In the operating room, Masimo SpHb has enabled us to more effectively monitor blood loss and better manage transfusions in surgery, while routine screening in the ED has helped us to more rapidly identify patients with anemia or internal bleeding."

Bertrand Debaene, MD, Anesthesiologist at the University
'/>"/>

SOURCE Masimo
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns
2. AARC Presentation Cites Masimo Patient SafetyNet as Key Factor in Improving Patient Outcomes and Reducing Costs in Post-Acute Care Facilities
3. Masimo Reports Third Quarter 2008 Financial Results
4. New Clinical Studies Presented at the American Society of Anesthesiology (ASA) Annual Meeting Show Masimo Technologies Provide Advanced Clinical Intelligence
5. Five New Clinical Studies Show Value of Masimo PVI & PI
6. Masimo to Report Third Quarter 2008 Financial Results on October 27, 2008
7. Masimo Initiates Limited Release of First-Ever Noninvasive and Continuous Hemoglobin Monitors
8. Masimo Announces Desaturation Index 3D Alarm as Standard Feature in All Radical-7 Pulse CO-Oximetry Devices
9. Masimo to Present at Goldman Sachs 29th Annual Global Healthcare Conference
10. Masimo to Present at Deutsche Bank 33rd Annual Health Care Conference
11. Masimo Reports First Quarter 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...November24/PRNewswire-FirstCall/--deCODE,genetics,...noticefrom,theNasdaqStockMarketthattradinginthecom...09andaForm25-NSEwillbefiledwiththe,SecuritiesandEx...k,fromlistingonNasdaq,unlessthecompanyfilesanappea...hasfiledsuchanappeal,which,willstaythesuspensionan...
(Date:11/24/2009)...Newswire-Asia/--NODPharmaceuticalsInc.announced,th...entapplicationfor,itsnano-particleoraldeliveryorNO...tapproachtoincorporatepeptidesor,proteinsintobio-a...therwiseadministeredasinjections.NODtechnologyisap...ulardrugssuchasinsulin,interferon,growthhormone,e...
(Date:11/24/2009)...The FBI recently approved the Promega PowerPlex 16...n or generating DNA records for the National DNA I...I USA (PRWEB) -- The FBI recently approved the Pro...ratories participating in, or generating DNA recor... currently contains more than seven million profil...
(Date:11/24/2009)...09/PRNewswire-FirstCall/--ArenaPharmaceuticals,Inc...heduledtopresentatthePiperJaffray21stAnnualHealthC...e(8:30a.m.PacificTime)attheNewYorkPalaceHotelinNew...iveOfficer,isscheduledtoprovideanoverviewofthecomp...grams. ,, Aliveaudiowebcastofthepresentationwil...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...ransfer Paves the Way for the Phase III Clinical D...00 in Developing Countries, LEUVEN, Belgium, Sept..., a biotechnology company focused on vascular dise...the technology transfer to Bharat,Biotech Internat...re of,THR-100, a novel variant of Recombinant Stap...
...EIJING, Sept. 3 /Xinhua-PRNewswire-FirstCall/ -- C...asdaq: CMED ), a leading China-based,medical devi... advanced in-,vitro diagnostic products and high i... today announced that it will participate in Credi...a Day. Location: Shenzhen, China Date:...
...ARIS, September 2 Sanofi-aventis announced,today ...IMI 25 and STEEPLE,studies confirm clear net clini...vation myocardial infarction (STEMI) for Lovenox(R...IMI 25 and STEEPLE one year results were presented...f Cardiology (ESC) Congress in,Vienna, Austria. E...
Other Biology Technology:ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 2ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 3ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent 4New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome 2New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome 3New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome 4New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome 5
(Date:11/23/2009)... , DURHAM, N.H. University of New Hampshire mi...taling $498,115 to advance understanding of the ac...tential to enrich nutrient-poor and contaminated s...ture (USDA) awarded Tisa, a professor of molecular...plore the symbiotic relationship between the bacte...
(Date:11/23/2009)... , , University of Southern California biomedical...s to develop a new tool to help clinicians disting...ry from chronic problems manageable with drugs and...catheters inserted into the arteries feeding the h... ("lumen") of these blood vessels, often revealing...
(Date:11/23/2009)... , Amphibians like frogs and toads have existed f...rs didn,t, but a new aquatic fungus is threatening...icle in the November issue of Microbiology Today ... (Bd), was found to be associated with waves of a...eastern Australia in the 1990,s. Bd infects over 3...
Breaking Biology News(10 mins):UNH prof. receives nearly $500,000 to research environmentally significant plants 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2H D Smith Promotes Leadership to Fill Two Senior Roles 51210 1H D Smith Promotes Leadership to Fill Two Senior Roles 51210 2ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 1ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 2ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 3ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 4ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 5Study identifies potential fix for damaged knees 51203 1Study identifies potential fix for damaged knees 51203 2Study identifies potential fix for damaged knees 51203 3
...ngineers at MIT are developing a tiny sensor that ...dous gases, including toxic industrial chemicals a... current devices. , The researchers have taken th... spectrometry and shrunk them to fit in a device t... led by MIT Professor Akintunde Ibitayo Akinwande,...
...tes Xie Lab has published findings that begin to c...g stem cells within their cellular microenvironme...ays issue of Cell Stem Cell. , The Xie Lab demon...ovarian germline stem cells (GSCs), behaving like ...em cells for a position in the niche. They do so b...
... NY Cold Spring Harbor Laboratorys (CSHL) researc... by Joans Legacy: The Joan Scarangello Foundation ...nd CSHLs pioneering lung cancer research involving...e a trigger in non-small cell lung cancer, the lea..., The mutations, called epidermal growth factor r...
Other Biology News:MIT gas sensor is tiny, quick 2Cold Spring Harbor Laboratory's lung cancer research program awarded $100,000 grant 2
...D.471. Immunogen: Synthetic peptide derived from ...Specificity: Specific for the junctophilin-1 prote...rain and skeletal muscle homogenates frozen mouse ... Western blotting Immunohistochemistry(froz) Immun...
Mouse Anti-Human Laminin beta-1 / gamma-1 complex Monoclonal Antibody, Unconjugated, Clone 612C10 from Santa Cruz Biotechnology, Inc.
Rabbit Anti-JIP 1 Polyclonal Antibody, Unconjugated from BioVision
Mouse Anti-Mouse XBP-1 Monoclonal Antibody, Unconjugated, Clone F-4 from Santa Cruz Biotechnology, Inc.
Biology Products: